4 septiembre 2014
The U.S. Food and Drug Administration has approved a new immunotherapy drug to treat advanced melanoma, signaling a paradigm shift in the way the deadly skin cancer is treated. Melanoma incidence rates have been increasing for at least 30 years. An estimated 76,100 new cases of melanoma will be diagnosed in the U.S. in 2014, and nearly 10,000 Americans will die from the disease this year.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/FF7IrRsSDqk/140904183602.htm
